Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis

doi:10.4330/wjc.v14.i11.599

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4028)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-4) series.

Item

Count

PDF

233

WORD

HTML

1867

Figures (1-9)

186

Tables (1-4)

205

Sum=2538

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

184

Download

452

Sum=636

Publishing Process of This Article

Item

Count

Browse

263

Download

591

Sum=854

Nov 26, 2022 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. Nov 26, 2022; 14(11): 599-616
Published online Nov 26, 2022. doi: 10.4330/wjc.v14.i11.599

Full Size Figure Download Figure

Figure 2 Forest plot. A: Highlighting impact of SGLT2-I on FPG compared to placebo; B: SGLT2-I dose subgroup analysis performed for FPG. SGLT2-I: Sodium-glucose cotransporter 2 inhibitor; FPG: Fasting plasma glucose.

Citation: Olagunju A, Yamani N, Kenny D, Mookadam M, Mookadam F, Unzek S. Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis. World J Cardiol 2022; 14(11): 599-616
URL: https://www.wjgnet.com/1949-8462/full/v14/i11/599.htm
DOI: https://dx.doi.org/10.4330/wjc.v14.i11.599